Overall rank by patents
#33,209
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 15 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Shiga holds 8 US patents across 15 technology areas, rank #33,209 of 50,000 tracked assignees.
Shiga University OF Medical Science has been granted 8 US utility patents between 2015 and 2022, placing Shiga University OF Medical Science at rank #33,209 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.4 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Shiga University OF Medical Science is one of the more focused assignees in the PatentsView dataset. By volume, Shiga sits between Shenzhen Vimai Technology Co., Limited (8 patents, rank #33,205) and Sicam S.r.l. (8 patents, rank #33,213) - the closest US assignees by grant volume. The composite Innovation Score of 30.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 5 in the 2015–2019 window, a -40% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Shiga University OF Medical Science's 11.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Shiga University OF Medical Science against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SHENZHEN VIMAI TECHNOLOGY CO., LIMITED
8 patents
SHENZHEN XHORSE ELECTRONICS CO., LTD
8 patents
SHENZHEN YUEJIANG TECHNOLOGY CO., LTD.
8 patents
SHIELDPRO, LLC
8 patents
SHIMADZU RESEARCH LABORATORY (SHANGHAI) CO. LTD.
8 patents
SHINN FU CORPORATION
8 patents
SHOPPER SCIENTIST LLC
8 patents
SICAM S.R.L.
8 patents
SHIGA UNIVERSITY OF MEDICAL SCIENCE
8 patents
What this shows Shiga holds 8 patents at rank #33,209, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #33,209 in granted patent volume.
Other assignees with the most granted patents in Shiga's primary technology class.
Shiga's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
30 Top 66% higher than 34% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 25.0% |
| 2017 | 2 | 25.0% |
| 2019 | 1 | 12.5% |
| 2020 | 1 | 12.5% |
| 2021 | 1 | 12.5% |
| 2022 | 1 | 12.5% |
Top 15 of 15 technology areas
Overall rank by patents
#33,209
Across all tracked assignees
30.3 out of 100
How to use this portfolio
Shiga's 8 grants land it in the top 66% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.